Inclusion criteria: |
---|
Intracameral fibrin membranes or clots after ECCE or phacoemulsification with PC-IOL |
Age: 18–90 years |
Able to participate for the entire follow up period |
Exclusion criteria: |
Known hypersensitivity to active ingredients or excipients of the study medication |
Uncertain compliance |
Known coagulopathy |
Systemic thrombocyte aggregation inhibitors or coagulation inhibitors |
Intraoperative posterior capsule rupture |